nach oben

Erschienen in:

03.01.2022 | COVID-19 | Review Zur Zeit gratis

Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination

verfasst von: Rupinder Kaur, Shareen Singh, Thakur Gurjeet Singh, Pragati Sood, Jiki Robert

Erschienen in: Inflammopharmacology | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

A novel coronavirus disease (COVID-19), caused by a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was discovered in Wuhan, China, in December 2019, and the world has suffered from a pandemic. As of 22nd March 2020, at least 185 countries worldwide had been affected by COVID-19. SARS-CoV-2, leading to COVID-19 pneumonia, infects cells through ACE-2 receptors. The disease has different clinical signs and symptoms, including chills, high fever, dyspnea, and cough. Other symptoms including haemoptysis, myalgia, diarrhoea, expectoration, and fatigue may also occur. The rapid rise in confirmation cases is severe in preventing and controlling COVID-19. In this review, the article will explore and evaluate the insights into how COVID influences patients with other comorbid conditions such as cardiovascular disease, diabetes, Parkinson’s, and how conditions Urolithiasis, anosmia, and anuria may develop after infection. The virus mutates and the variants are now prevalent in the present scenario where the world stands in eradicating the pandemic by looking into the development of vaccines by several countries and how the vaccination can temporarily help prevent COVID spread.

Abdel Massih AF, Mahrous R, Taha A, Saud A, Osman A, Kamel B, Yacoub E, Menshawey E, Ismail HA, Aita L, Dous M (2020) The potential use of ABO blood group system for risk stratification of COVID-19. Med Hypotheses 145:110343. https://doi.org/10.1016/j.mehy.2020.110343CrossRef

Ad’hiah AH, Abdullah MH, Alsudani MY, Shnawa RM, Al-Sa’ady AJ, Allami RH, Misha’al KI, Jassim IA, Taqi EA (2020) Association between ABO blood groups and susceptibility to COVID-19: profile of age and gender in Iraqi patients. Egypt J Med Hum Genet 21:1CrossRef

Ahmad T, Rodriguez-Morales AJ (2019) Emergence of COVID-19 (formerly 2019-novel Coronavirus): a new threat from China. Rev Panam Enferm Infecc 2(2):37–38. http://orcid.org/0000-0001-8793-273X

Akkawi AR, Ghazal M (2021) COVID-19 and cardiac arrhythmias: a review of the literature. Cureus. https://doi.org/10.7759/cureus.17797CrossRefPubMedPubMedCentral

Al-Ani S, Chehade S, Lazo-Langner A (2020) Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res 192:152–160. https://doi.org/10.1016/j.thromres.2020.05.039CrossRefPubMedPubMedCentral

Al-Sadeq DW, Nasrallah GK (2020) The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review. Int J Infect Dis 98:372–380CrossRefPubMedPubMedCentral

Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, Hurst JR (2020) Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One 15:e0233147. https://doi.org/10.1371/journal.pone.0233147CrossRefPubMedPubMedCentral

Antonucci M, Recupero SM, Marzio V, De Dominicis M, Pinto F, Foschi N, Di Gianfrancesco L, Bassi P, Ragonese M (2020) The impact of COVID-19 outbreak on urolithiasis emergency department admissions, hospitalizations and clinical management in central Italy: a multicentric analysis. Actas Urol Esp 44:611–616. https://doi.org/10.1016/j.acuroe.2020.10.006 (English Edition)CrossRefPubMedPubMedCentral

Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S (2020) COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. https://doi.org/10.1016/S2213-8587(20)30238-2CrossRefPubMedPubMedCentral

Aw D, Silva AB, Palmer DB (2007) Immunosenescence: emerging challenges for an ageing population. Immunology 120:435–446. https://doi.org/10.1111/j.1365-2567.2007.02555.xCrossRefPubMedPubMedCentral

Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A (2020) Myocardial injury and COVID-19: possible mechanisms. Life Sci 253:117723. https://doi.org/10.1016/j.lfs.2020.117723CrossRefPubMedPubMedCentral

Baille G, Chenivesse C, Perez T, Machuron F, Dujardin K, Devos D, Moreau C (2019) Dyspnea: an underestimated symptom in Parkinson’s disease. Parkinsonism RelatDisord 60:162–166. https://doi.org/10.1016/j.parkreldis.2018.09.001CrossRef

Balakrishnan VS (2020) The arrival of Sputnik V. Lancet Infect Dis 20:1128. https://doi.org/10.1016/S1473-3099(20)30709-XCrossRefPubMedPubMedCentral

Baldi E, Sechi GM, Mare C, Canevari F, Brancaglione A, Primi R, Klersy C, Palo A, Contri E, Ronchi V, Beretta G (2020) Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy. N Engl J Med 383:496–498. https://doi.org/10.1056/NEJMc2010418CrossRefPubMed

Banerjee AB, Singh TG, Prashar A (2021) BCG vaccine, a ray of hope in treating Severe Acute Respiratory Syndrome (SARS). Infect Disord Drug Targets 21(5):e270421186935. https://doi.org/10.2174/1871526520666201016150501CrossRefPubMed

Bansal M (2020) Cardiovascular disease and COVID-19. Diabetes Metab Syndr: Clin Res Rev 14:247–250. https://doi.org/10.1016/j.dsx.2020.03.013CrossRef

Bassetti M, Corcione S, Dettori S, Lombardi A, Lupia T, Vena A, De Rosa FG, Gori A, Giacobbe DR (2021) Antiviral treatment selection for SARS-CoV-2 pneumonia. Expert Rev Respir Med 22:1–8. https://doi.org/10.1080/17476348.2021.1927719CrossRef

Bautista-Vargas M, Bonilla-Abadía F, Cañas CA (2020) Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19. J Thromb Thrombolysis 50:479–483. https://doi.org/10.1007/s11239-020-02172-xCrossRefPubMed

Bhatla A, Mayer MM, Adusumalli S, Hyman MC, Oh E, Tierney A, Deo R (2020) COVID-19 and cardiac arrhythmias. Heart Rhythm 17:1439–1444. https://doi.org/10.1016/j.hrthm.2020.06.016CrossRefPubMedPubMedCentral

Bloem BR, Trenkwalder C, Sanchez-Ferro A, Kalia LV, Alcalay R, Chiang HL, Kang UJ, Goetz C, Brundin P, Papa SM (2021) COVID-19 vaccination for persons with Parkinson’s disease: light at the end of the tunnel? Parkinson’s Dis 28:1–5. https://doi.org/10.3233/JPD-212573CrossRef

Boika AV (2020) A post-COVID-19 Parkinsonism in the future? J Mov Disord. https://doi.org/10.1002/mds.28117CrossRef

Bonsignore MR, Baiamonte P, Mazzuca E, Castrogiovanni A, Marrone O (2019) Obstructive sleep apnea and comorbidities: a dangerous liaison. Multidiscip Respir Med 14:1–12. https://doi.org/10.1186/s40248-019-0172-9CrossRef

Cetinkaya EA (2020) Coincidence of COVID-19 infection and smell—taste perception disorders. J Craniofac Surg. https://doi.org/10.1097/SCS.0000000000006601CrossRefPubMedPubMedCentral

Chen PL, Lee NY, Cia CT, Ko WC, Hsueh PR (2020) A review of treatment of coronavirus disease 2019 (COVID-19): therapeutic repurposing and unmet clinical needs. Front Pharmacol. https://doi.org/10.3389/fphar.2020.584956CrossRefPubMedPubMedCentral

Chung JY, Thone MN, Kwon YJ (2021) COVID-19 vaccines: the status and perspectives in delivery points of view. Adv Drug Deliv Rev 170:1–25. https://doi.org/10.1016/j.addr.2020.12.011CrossRefPubMed

Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Uriel N (2020) COVID-19 and cardiovascular disease. Circulation 141:1648–1655. https://doi.org/10.1161/CIRCULATIONAHA.120.046941CrossRefPubMed

Cook TM (2020) The importance of hypertension as a risk factor for severe illness and mortality in COVID-19. Anaesthesia 75:976. https://doi.org/10.1111/anae.15103CrossRefPubMedPubMedCentral

Coromilas EJ, Kochav S, Goldenthal I, Biviano A, Garan H, Goldbarg S, Kim JH, Yeo I, Tracy C, Ayanian S, Akar J (2021) Worldwide survey of COVID-19—associated arrhythmias. Circ: Arrhythm Electrophysiol 14:e009458. https://doi.org/10.1161/CIRCEP.120.008719CrossRef

Cristelo C, Azevedo C, Marques JM, Nunes R, Sarmento B (2020) SARS-CoV-2 and diabetes: new challenges for the disease. Diabetes Res Clin Pract 164:108228. https://doi.org/10.1016/j.diabres.2020.108228CrossRefPubMedPubMedCentral

Cui S, Chen S, Li X, Liu S, Wang F (2020) Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 18(6):1421–1424. https://doi.org/10.1111/jth.14830CrossRefPubMed

Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17(3):181–192. https://doi.org/10.1038/s41579-018-0118-9CrossRefPubMed

Cui X, Zhao Z, Zhang T, Guo W, Guo W, Zheng J, Zhang J, Dong C, Na R, Zheng L, Li W, Liu Z, Ma J, Wang J, He S, Xu Y, Si P, Shen Y, Cai C (2021) A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19). J Med Virol 93:1057–1069. https://doi.org/10.1002/jmv.26398CrossRefPubMed

Cure E, Cure MC (2020) Comment on “Hearing loss and COVID-19: a note.” Am J Otolaryngol 41:102513. https://doi.org/10.1016/j.amjoto.2020.102513CrossRefPubMedPubMedCentral

Dash GC, Subhadra S, Turuk J, Parai D, Rath S, Sabat J, Rout UK, Kanungo S, Choudhary HR, Nanda RR, Pattnaik M, Pati S, Bhattacharya D (2021) Breakthrough SARS-CoV-2 infections among BBV-152 (COVAXIN®) and AZD1222 (COVISHIELDT^M ) recipients: report from eastern state of India. J Med Virol. https://doi.org/10.1002/jmv.27382CrossRefPubMedPubMedCentral

De Siqueira JV, Almeida LG, Zica BO, Brum IB, Barceló A, de Siqueira Galil AG (2020) Impact of obesity on hospitalizations and mortality, due to COVID-19: a systematic review. Obes Res Clin Pract 14(5):398–403. https://doi.org/10.1016/j.orcp.2020.07.005CrossRefPubMedPubMedCentral

Deepika AS, Kaur R, Singh TG, Singh M, Satija S, Singh R (2019) Prescribing pattern of antihypertensive drugs in a tertiary care hospital: a review. Plant Arch 19(2):1311–1316

Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, Veronese N, Smith L (2020) Coronavirus diseases (COVID-19) current status and future perspectives: a narrative review. Int J Environ Res Public Health 17:2690. https://doi.org/10.3390/ijerph17082690CrossRefPubMedCentral

Ding H, Dhima K, Lockhart KC, Locascio JJ, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Hayes MT, Sohur US, Wills A-M, Mollenhauer B, Flaherty AW, Hung AY, Mejia N, Khurana V, Gomperts SN, Selkoe DJ, Schwarzschild MA, Schlossmacher MG, Hyman BT, Sudarsky LR, Growdon JH, Scherzer CR (2013) Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard biomarker study. Neurology 81:1531–1537. https://doi.org/10.1212/wnl.0b013e3182a95818CrossRefPubMedPubMedCentral

Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, Anderson RM (2003) Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. The Lancet 361:1761–1766. https://doi.org/10.1016/S0140-6736(03)13410-1CrossRef

Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Parikh SA (2020) Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 75:2352–2371. https://doi.org/10.1016/j.jacc.2020.03.031CrossRefPubMedPubMedCentral

Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8:e21. https://doi.org/10.1016/S2213-2600(20)30116-8CrossRefPubMedPubMedCentral

Fearon C, Fasano A (2021) Parkinson’s disease and the COVID-19 pandemic. J Parkinsons Dis. https://doi.org/10.3233/JPD-202320 (Preprint)CrossRefPubMedPubMedCentral

Fernandez C, Rysä J, Almgren P, Nilsson J, Engström G, Orho-Melander M, Melander O (2018) Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality. J Intern Med 284:377–387. https://doi.org/10.1111/joim.12783CrossRefPubMedPubMedCentral

Fletcher-Sandersjöö A, Bellander BM (2020) Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review. Thromb Res 194:36–41. https://doi.org/10.1016/j.thromres.2020.06.027CrossRefPubMedPubMedCentral

Gérard C, Maggipinto G, Minon JM (2020) COVID-19 and ABO blood group: another viewpoint. Br J Haematol 190:e93–e94. https://doi.org/10.1111/bjh.16884CrossRefPubMed

Giovanetti M, Benedetti F, Campisi G, Ciccozzi A, Fabris S, Ceccarelli G, Tambone V, Caruso A, Angeletti S, Zella D, Ciccozzi M (2021) Evolution patterns of SARS-CoV-2: snapshot on its genome variants. BiochemBiophys Res Commun 538:88–91. https://doi.org/10.1016/j.bbrc.2020.10.102CrossRef

Gómez CA, Sun CK, Tsai I, Chang YP, Lin MC, Hung IY, Hung KC (2021) Mortality and risk factors associated with pulmonary embolism in coronavirus disease 2019 patients: a systematic review and meta-analysis. Sci Rep 11:1–13. https://doi.org/10.1038/s41598-021-95512-7CrossRef

Gopinathannair R, Merchant FM, Lakkireddy DR, Etheridge SP, Feigofsky S, Han JK, Russo AM (2020) COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol 59:329–336. https://doi.org/10.1007/s10840-020-00789-9CrossRefPubMedPubMedCentral

Grewal AK, Singh N, Singh TG (2019) Effects of resveratrol postconditioning on cerebral ischemia in mice: role of the sirtuin-1 pathway. Can J Physiol Pharmacol 97(11):1094–1101. https://doi.org/10.1139/cjpp-2019-0188 (Epub 2019 Jul 24 PMID: 31340128)CrossRefPubMed

Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE (2020) Extrapulmonary manifestations of COVID-19. Nat Med 26:1017–1032. https://doi.org/10.1038/s41591-020-0968-3CrossRefPubMed

Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, McInnes IB (2020) COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 116:1666–1687. https://doi.org/10.1093/cvr/cvaa106CrossRefPubMedPubMedCentral

Han AY, Mukdad L, Long JL, Lopez IA (2020) Anosmia in COVID-19: mechanisms and significance. Chem Senses 45:423–428CrossRef

Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA (2020) Thrombosis in COVID-19. Am J Hematol 95:1578–1589. https://doi.org/10.1002/ajh.25982CrossRefPubMedPubMedCentral

Harenberg J, Jonas JB, Trecca EM (2020) A liaison between sudden sensorineural hearing loss and SARS-CoV-2 infection. Thromb Haemost 120:1237–1239. https://doi.org/10.1055/s-0040-1714370CrossRefPubMed

Harikrishnan P (2020) Gustatory dysfunction as an early symptom in COVID-19 screening. J Craniofac Surg. https://doi.org/10.1097/SCS.0000000000006797CrossRefPubMedPubMedCentral

Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pöhlmann S (2014) TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol 88:1293–1307. https://doi.org/10.1128/JVI.02202-13CrossRefPubMedPubMedCentral

Ho JC, Chan KN, Hu WH, Lam WK, Zheng L, Tipoe GL, Tsang KW (2001) The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. Am J Respir Crit Care Med 163:983–988. https://doi.org/10.1164/ajrccm.163.4.9909121CrossRefPubMed

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271–280. https://doi.org/10.1016/j.cell.2020.02.052CrossRefPubMedPubMedCentral

Hribar CA, Cobbold PH, Church FC (2020) Potential role of vitamin D in the elderly to resist COVID-19 and to slow progression of Parkinson’s disease. Brain Sci 10:284. https://doi.org/10.3390/brainsci10050284CrossRefPubMedCentral

Hung IF, Yuen KY (2020) Early triple antiviral therapy for COVID-19–Authors’ reply. The Lancet 396:1488. https://doi.org/10.1016/S0140-6736(20)32268-6CrossRef

Ilie PC, Stefanescu S, Smith L (2020) The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res 32:1195–1198. https://doi.org/10.1007/s40520-020-01570-8CrossRefPubMedPubMedCentral

Indari O, Jakhmola S, Manivannan E, Jha HC (2021) An update on antiviral therapy against SARS-CoV-2: how far have we come? Front Pharmacol 12:133. https://doi.org/10.3389/fphar.2021.632677CrossRef

Ji T, Liu Z, Wang G, Guo X, Lai C, Chen H, Zhou Q (2020) Detection of COVID-19: A review of the current literature and future perspectives. Biosens Bioelectron 166:112455. https://doi.org/10.1016/j.bios.2020.112455CrossRefPubMedPubMedCentral

Kahn JS, McIntosh K (2005) History and recent advances in coronavirus discovery. Pediatr Infect Dis J 24:S223–S227. https://doi.org/10.1097/01.inf.0000188166.17324.60CrossRefPubMed

Kanwal A, Agarwala A, Martin LW, Handberg EM, Yang E (2020) COVID-19 and hypertension: what we know and don't know. Am Coll Cardiol

Khan A (2018) Prevalence, pathophysiological mechanisms and factors affecting urolithiasis. Int Urol Nephrol 50:799–806. https://doi.org/10.1007/s11255-018-1849-2CrossRefPubMed

Kochav SM, Coromilas E, Nalbandian A, Ranard LS, Gupta A, Chung MK (2020) Cardiac arrhythmias in COVID-19 infection. Circ Arrhythm Electrophysiol 13:e008719CrossRefPubMedPubMedCentral

Koyama RG, Drager LF, Lorenzi-Filho G, Cintra FD, Pereira AC, Poyares D, Pedrazzoli M (2009) Reciprocal interactions of obstructive sleep apnea and hypertension associated with ACE I/D polymorphism in males. Sleep Med 10:1107–1111. https://doi.org/10.1016/j.sleep.2008.12.012CrossRefPubMed

Koyama T, Platt D, Parida L (2020) Variant analysis of SARS-CoV-2 genomes. Bull World Health Organ 98:495–504. https://doi.org/10.2471/BLT.20.253591CrossRefPubMedPubMedCentral

Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 55:105924. https://doi.org/10.1016/j.ijantimicag.2020.105924CrossRefPubMedPubMedCentral

Latz CA, DeCarlo C, Boitano L, Png CM, Patell R, Conrad MF, Eagleton M, Dua A (2020) Blood type and outcomes in patients with COVID-19. Ann Hematol 99:2113–2118. https://doi.org/10.1007/s00277-020-04169-1CrossRefPubMedPubMedCentral

Lee Y, Min P, Lee S, Kim SW (2020) Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. https://doi.org/10.3346/jkms.2020.35.e174CrossRefPubMedPubMedCentral

Lim S, Bae JH, Kwon HS, Nauck MA (2021) COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 17(1):11–30. https://doi.org/10.1038/s41574-020-00435-4CrossRefPubMed

Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Liu HG (2020) Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J 133:1025. https://doi.org/10.1097/CM9.0000000000000744CrossRefPubMedPubMedCentral

Long B, Brady WJ, Koyfman A, Gottlieb M (2020) Cardiovascular complications in COVID-19. Am J Emerg Med 38:1504–1507. https://doi.org/10.1016/j.ajem.2020.04.048CrossRefPubMedPubMedCentral

Longobardi L, Di Giorgio A, Perrotta F, Costigliola A, Cerqua FS, Cioffi G, Stefanelli F (2016) Bronchial asthma in the elderly patient. J Gerontol Geriatr 64:55–65

Maas MB, Kim M, Malkani RG, Abbott SM, Zee PC (2020) Obstructive sleep apnea and risk of COVID-19 infection, hospitalization and respiratory failure. Sleep Breath 29:1–3. https://doi.org/10.1007/s11325-020-02203-0CrossRef

Mahase E (2020) Covid-19: moderna applies for US and EU approval as vaccine trial reports 94.1% efficacy. BMJ 371:m4709. https://doi.org/10.1136/bmj.m4709CrossRefPubMed

Manolis AS, Manolis AA, Manolis TA, Apostolopoulos EJ, Papatheou D, Melita H (2020) COVID-19 infection and cardiac arrhythmias. Trends Cardiovasc Med. https://doi.org/10.1016/j.tcm.2020.08.002CrossRefPubMedPubMedCentral

Marshall M (2021) COVID’s toll on smell and taste: what scientists do and don’t know. Nature 589:342–343CrossRefPubMed

Miller MA, Cappuccio FP (2020) A systematic review of COVID-19 and obstructive sleep apnoea. Sleep Med Rev 8:101382. https://doi.org/10.1016/j.smrv.2020.101382CrossRef

Mitchell F (2020) Vitamin-D and COVID-19: do deficient risk a poorer outcome? Lancet Diabetes Endocrinol 8:570. https://doi.org/10.1016/S2213-8587(20)30183-2CrossRefPubMedPubMedCentral

Mustafa MW (2020) Audiological profile of asymptomatic Covid-19 PCR-positive cases. Am J Otolaryngol 41:102483. https://doi.org/10.1016/j.amjoto.2020.102483CrossRefPubMedPubMedCentral

Nagashima K, Wege H, Meyermann R, Ter Meulen V (1978) Corona virus induced subacute demyelinating encephalomyelitis in rats: a morphological analysis. Acta Neuropathol 44:63–70. https://doi.org/10.1007/BF00691641CrossRefPubMedPubMedCentral

Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, Gao Z (2020) Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. J Crit Care 24:1–10. https://doi.org/10.1186/s13054-020-03120-0CrossRef

Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC (2020) COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 17:543–558. https://doi.org/10.1038/s41569-020-0413-9CrossRefPubMedPubMedCentral

Page EM, Ariëns RA (2021) Mechanisms of thrombosis and cardiovascular complications in COVID-19. Thromb Res 200:1–8. https://doi.org/10.1016/j.thromres.2021.01.005CrossRefPubMedPubMedCentral

Pal M, Berhanu G, Desalegn C, Kandi V (2020) Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus. https://doi.org/10.7759/cureus.7423CrossRefPubMedPubMedCentral

Paramasivam A, Priyadharsini JV, Raghunandhakumar S, Elumalai P (2020) A novel COVID-19 and its effects on cardiovascular disease. Hypertens Res 43:729–730. https://doi.org/10.1038/s41440-020-0461-xCrossRefPubMedPubMedCentral

Peng L, Shen L, Xu J, Tian X, Liu F, Wang J, Tian G, Yang J, Zhou L (2021) Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures. Sci Rep 11:1–1. https://doi.org/10.1038/s41598-021-83737-5CrossRef

Petersen E, Koopmans M, Go U, Hamer DH, Petrosillo N, Castelli F, Simonsen L (2020) Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(20)30484-9CrossRefPubMedPubMedCentral

Raheem AA, Alowidah I, Soliman M, Haresy M, Almozeni A, Althagafi S, Almousa M, Alturki M (2020) Urolithiasis treatment options during COVID-19 pandemic: review of current recommendations and triage systems. Afr J Urol 26:1–7. https://doi.org/10.1186/s12301-020-00085-yCrossRef

Rehman M, Gondal A, Rehman NU (2020) Atypical manifestation of COVID-19-induced myocarditis. Cureus. https://doi.org/10.7759/cureus.8685CrossRefPubMedPubMedCentral

Rostami M, Mansouritorghabeh H (2020) D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol 13:1265–1275. https://doi.org/10.1080/17474086.2020.1831383CrossRefPubMed

Rubin EJ, Longo DL (2020) SARS-CoV-2 Vaccination—an ounce (actually, much less) of prevention. N Engl J Med 383:2677–2678. https://doi.org/10.1056/NEJMe2034717CrossRefPubMed

Salles-Gándara P, Rojas-Fernandez A, Salinas-Rebolledo C, Milan-Sole A (2020) The potential role of SARS-COV-2 in the pathogenesis of Parkinson’s disease. Front Neurol 11:1044. https://doi.org/10.3389/fneur.2020.01044CrossRefPubMedPubMedCentral

Samudrala PK, Kumar P, Choudhary K, Thakur N, Wadekar GS, Dayaramani R, Alexander A (2020) Virology, pathogenesis, diagnosis and in-line treatment of COVID-19. Eur J Pharmacol 883:173375. https://doi.org/10.1016/j.ejphar.2020.173375CrossRefPubMedPubMedCentral

Saniasiaya J (2021) Hearing loss in SARS-CoV-2: what do we know? Ear Nose Throat J 100:152S-154S. https://doi.org/10.1177/0145561320946902CrossRefPubMedPubMedCentral

Santesmasses D, Castro JP, Zenin AA, Shindyapina AV, Gerashchenko MV, Zhang B, Gladyshev VN (2020) COVID-19 is an emergent disease of aging. Aging Cell 19:e13230. https://doi.org/10.1111/acel.13230CrossRefPubMedPubMedCentral

Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, Altaf M (2020) Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. https://doi.org/10.1007/s42399-020-00363-4CrossRefPubMedPubMedCentral

Scorza FA, Fiorini AC, Scorza CA, Finsterer J (2018) Cardiac abnormalities in Parkinson’s disease and Parkinsonism. J ClinNeurosci 53:1–5. https://doi.org/10.1016/j.jocn.2018.04.031CrossRef

Sharma VK, Singh TG (2020a) Chronic stress and diabetes mellitus: interwoven pathologies. Curr Diabetes Rev 16(6):546–556. https://doi.org/10.2174/1573399815666191111152248 (PMID: 31713487)CrossRefPubMed

Sharma VK, Singh TG (2020b) Insulin resistance and bioenergetic manifestations: targets and approaches in Alzheimer’s disease. Life Sci 262:118401. https://doi.org/10.1016/j.lfs.2020.118401 (Epub 2020 Sep 12 PMID: 32926928)CrossRefPubMed

Sharma VK, Singh TG (2020c) Navigating Alzheimer’s disease via chronic stress: the role of glucocorticoids. Curr Drug Targets 21(5):433–444. https://doi.org/10.2174/1389450120666191017114735 (PMID: 31625472)CrossRefPubMed

Sharma A, Khan H, Singh TG, Grewal AK, Najda A, Kawecka-Radomska M, Kamel M, Altyar AE, Del-Daim MM (2021a) Pharmacological modulation of ubiquitin-proteasome pathways in oncogenic signaling. Int J Mol Sci 22(21):11971. https://doi.org/10.3390/ijms222111971 (PMID:34769401;PMCID:PMC8584958)CrossRefPubMedPubMedCentral

Sharma T, Kaur D, Grewal AK, Singh TG (2021b) Therapies modulating insulin resistance in Parkinson’s disease: a cross talk. Neurosci Lett 749:135754. https://doi.org/10.1016/j.neulet.2021.135754 (Epub 2021 Feb 18 PMID: 33610666)CrossRefPubMed

Sher L (2020) COVID-19, anxiety, sleep disturbances and suicide. Sleep Med 70:124. https://doi.org/10.1016/j.sleep.2020.04.019CrossRefPubMedPubMedCentral

Silveira MM, Moreira GMSG, Mendonça M (2021) DNA vaccines against COVID-19: perspectives and challenges. Life Sci 267:118919. https://doi.org/10.1016/j.lfs.2020.118919CrossRefPubMed

Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, Verkindt H (2020) High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity 28:1195–1199. https://doi.org/10.1002/oby.22831CrossRefPubMed

Singh S, Singh TG (2020) Role of nuclear factor Kappa B (NF-κB) signalling in neurodegenerative diseases: an mechanistic approach. Curr Neuropharmacol 18(10):918–935. https://doi.org/10.2174/1570159X18666200207120949.PMID:32031074;PMCID:PMC7709146CrossRefPubMedPubMedCentral

Singh AK, Gupta R, Ghosh A, Misra A (2020a) Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr: Clin Res Rev 14:303–310. https://doi.org/10.1016/j.dsx.2020.04.004CrossRef

Singh R, Rao HK, Singh TG (2020b) Advanced glycated end products (ages) in diabetes and its complications: an insight. Plant Arch 20(1):3838–3841

Singh TG, Sharma R, Kaur A, Dhiman S, Singh R (2020c) Evaluation of renoprotective potential of Ficus religiosa in attenuation of diabetic nephropathy in rats. Obes Med 19:100268CrossRef

Singh R, Rao HK, Singh TG (2021) Comparison of safety and efficacy of pregabalin, duloxetine and their combination with epalrestat in diabetic neuropathy: a prospective, double-blind, randomized, controlled Trial. J Appl Pharm Sci 11:071–079

Smetanová J, Střížová Z, Bartůňková J, Milota T (2020) Principles and new perspectives in the vaccination against SARS-CoV-2 virus. Cas Lek Cesk 159:298–302PubMed

Soleimanpour S, Yaghoubi A (2021) COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines 20:23–44. https://doi.org/10.1080/14760584.2021.1875824CrossRefPubMed

Sorbera C, Brigandì A, Cimino V, Bonanno L, Ciurleo R, Bramanti P, Marino S (2021) The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: clinical case series study. PLoS One 16:e0251313. https://doi.org/10.1371/journal.pone.0251313CrossRefPubMedPubMedCentral

South AM, Diz DI, Chappell MC (2020) COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol 318:H1084–H1090. https://doi.org/10.1152/ajpheart.00217.2020CrossRefPubMedPubMedCentral

Srivastava K (2020) Association between COVID-19 and cardiovascular disease. Int J Cardiol Heart Vasc. https://doi.org/10.1016/j.ijcha.2020.100583CrossRefPubMedPubMedCentral

Sriwijitalai W, Wiwanitkit V (2020) Hearing loss and COVID-19: a note. Am J Otolaryngol. https://doi.org/10.1016/j.amjoto.2020.102473CrossRefPubMedPubMedCentral

Subramaniam A, Elsayed RM (2021) Does obesity increase the morbidity and mortality in COVID-19 patients. evidence based clinical review. Sch J App Med Sci 2:248–252. https://doi.org/10.36347/sjams.2021.v09i02.014CrossRef

Sulzer D, Antonini A, Leta V, Nordvig A, Smeyne RJ, Goldman JE, Al-Dalahmah O, Zecca L, Sette A, Bubacco L, Meucci O (2020) COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside. NPJ Parkinsons Dis 6:1. https://doi.org/10.1038/s41531-020-00123-0CrossRef

Syed MA, Al Nuaimi AS, Nasrallah GK, Althani AA, Yassine HM, Zainel A, AAbdulmalik MA (2021) Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above. BMC Infect Dis 21:1–11. https://doi.org/10.1186/s12879-021-06251-zCrossRef

Tadic M, Cuspidi C, Mancia G, Dell’Oro R, Grassi G (2020) COVID-19, hypertension and cardiovascular diseases: should we change the therapy? Pharmacol Res Commun 158:104906. https://doi.org/10.1016/j.phrs.2020.104906CrossRef

Tanaka SI, Isoda F, Ishihara Y, Kimura M, Yamakawa T (2001) T lymphopaenia in relation to body mass index and TNF-α in human obesity: adequate weight reduction can be corrective. Clin Endocrinol 54:347–354. https://doi.org/10.1046/j.1365-2265.2001.1139cn2155.xCrossRef

Tang JW, Tambyah PA, Hui DS (2021) Emergence of a new SARS-CoV-2 variant in the UK. J Infect 82:e27–e28. https://doi.org/10.1016/j.jinf.2020.12.024CrossRefPubMed

Tefik T, Guven S, Villa L, Gokce MI, Kallidonis P, Petkova K, Kiremit MC, Sonmez MG, De Lorenzis E, Eryildirim B, Sarica K (2020) Urolithiasis practice patterns following the COVID-19 pandemic: overview from the EULIS collaborative research working group. Eur Urol Suppl. https://doi.org/10.1016/j.eururo.2020.04.057CrossRef

Thapa K, Verma N, Singh TG, Kaur Grewal A, Kanojia N, Rani L (2021) COVID-19-associated acute respiratory distress syndrome (CARDS): mechanistic insights on therapeutic intervention and emerging trends. Int Immunopharmacol 101(Pt A):108328. https://doi.org/10.1016/j.intimp.2021.108328CrossRefPubMedPubMedCentral

Tison GH, Avram R, Kuhar P, Abreau S, Marcus GM, Pletcher MJ, Olgin JE (2020) Worldwide effect of COVID-19 on physical activity: a descriptive study. Ann Intern Med 173:767–770. https://doi.org/10.7326/M20-2665CrossRefPubMed

Tomasoni D, Italia L, Adamo M, Inciardi RM, Lombardi CM, Solomo SD, Metra M (2020) COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail 22:957–966. https://doi.org/10.1002/ejhf.1871CrossRefPubMed

Trecca EMC, Gelardi M, Cassano M (2020) COVID-19 and hearing difficulties. Am J Otolaryngol 41:102496. https://doi.org/10.1016/j.amjoto.2020.102496CrossRefPubMedPubMedCentral

Tsatsakis A, Calina D, Falzone L, Petrakis D, Mitrut R, Siokas V, Docea AO (2020) SARS-CoV-2 pathophysiology and its clinical implications: an integrative overview of the pharmacotherapeutic management of COVID-19. Food ChemToxicol 146:111769. https://doi.org/10.1016/j.fct.2020.111769CrossRef

Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T (2016) EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol 69(Suppl.1):468–474. https://doi.org/10.1016/j.eururo.2015.07.040CrossRefPubMed

Unudurthi SD, Luthra P, Bose RJ, McCarthy J, Kontaridis MI (2020) Cardiac inflammation in COVID-19: lessons from heart failure. Life Sci. https://doi.org/10.1016/j.lfs.2020.118482CrossRefPubMedPubMedCentral

Van Nieuwkoop C (2020) COVID-19 associated pulmonary thrombosis. Thromb Res 191:151. https://doi.org/10.1016/j.thromres.2020.04.042CrossRefPubMedPubMedCentral

Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, Subramaniam MD (2020) COVID-19: a promising cure for the global panic. Sci Total Environ 725:138277. https://doi.org/10.1016/j.scitotenv.2020.138277CrossRefPubMedPubMedCentral

Vishwakarma S, Singh S, Singh TG (2021) Pharmacological modulation of cytokines correlating neuroinflammatory cascades in epileptogenesis. Mol Biol Rep. https://doi.org/10.1007/s11033-021-06896-8 (Epub ahead of print. PMID: 34751915)CrossRefPubMed

Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181:281–292. https://doi.org/10.1016/j.cell.2020.02.058CrossRefPubMedPubMedCentral

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323:1061–1069. https://doi.org/10.1001/jama.2020.1585CrossRefPubMedPubMedCentral

Wenzel P, Kopp S, Göbel S, Jansen T, Geyer M, Hahn F, Münzel T (2020) Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab. Cardiovasc Res 116:1661–1663. https://doi.org/10.1093/cvr/cvaa160CrossRefPubMed

www.Clinicaltrials.gov.in

Yavuz S, Ünal S (2020) Antiviral treatment of COVID-19. Turk J Med Sci 21(50):611–619CrossRef

Zheng YY, Ma YT, Zhang JY, Xie X (2020a) COVID-19 and the cardiovascular system. Nat Rev Cardiol 17:259–260. https://doi.org/10.1038/s41569-020-0360-5CrossRefPubMed

Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Tang W (2020b) Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect 81:e16–e25. https://doi.org/10.1016/j.jinf.2020.04.021CrossRefPubMedPubMedCentral

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Cao B (2020) Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 395:1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3CrossRef

Titel: Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination
verfasst von: Rupinder Kaur
Shareen Singh
Thakur Gurjeet Singh
Pragati Sood
Jiki Robert
Publikationsdatum: 03.01.2022
Verlag: Springer International Publishing
Schlagwort: COVID-19
Erschienen in: Inflammopharmacology / Ausgabe 1/2022
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-021-00904-w

Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-κB signaling in an experimental model

Original Article

Anti-inflammatory and anti-COVID-19 effect of a novel polyherbal formulation (Imusil) via modulating oxidative stress, inflammatory mediators and cytokine storm

Zur Zeit gratis
COVID-19
Original Article

Correction to: The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case–control study

Zur Zeit gratis
COVID-19
Correction

Topical phenytoin administration accelerates the healing of acetic acid-induced colitis in rats: evaluation of transforming growth factor-beta, platelet-derived growth factor, and vascular endothelial growth factor

Original Article

Therapeutic benefits of flavonoids against neuroinflammation: a systematic review

Review

Curcumin and n-acetylcysteine cocrystal produced with supercritical solvent: characterization, solubility, and preclinical evaluation of antinociceptive and anti-inflammatory activities

Original Article

Springer Medizin

Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination

Abstract

Weitere Artikel der Ausgabe 1/2022

Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-κB signaling in an experimental model

Anti-inflammatory and anti-COVID-19 effect of a novel polyherbal formulation (Imusil) via modulating oxidative stress, inflammatory mediators and cytokine storm

Correction to: The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case–control study

Topical phenytoin administration accelerates the healing of acetic acid-induced colitis in rats: evaluation of transforming growth factor-beta, platelet-derived growth factor, and vascular endothelial growth factor

Therapeutic benefits of flavonoids against neuroinflammation: a systematic review

Curcumin and n-acetylcysteine cocrystal produced with supercritical solvent: characterization, solubility, and preclinical evaluation of antinociceptive and anti-inflammatory activities

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-κB signaling in an experimental model

Anti-inflammatory and anti-COVID-19 effect of a novel polyherbal formulation (Imusil) via modulating oxidative stress, inflammatory mediators and cytokine storm

Correction to: The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case–control study

Topical phenytoin administration accelerates the healing of acetic acid-induced colitis in rats: evaluation of transforming growth factor-beta, platelet-derived growth factor, and vascular endothelial growth factor

Therapeutic benefits of flavonoids against neuroinflammation: a systematic review

Curcumin and n-acetylcysteine cocrystal produced with supercritical solvent: characterization, solubility, and preclinical evaluation of antinociceptive and anti-inflammatory activities